Commure

Commure Ambient AI drafts the clinical note from the recorded encounter, and the same product line generates CPT and ICD-10 codes, modifiers, charge headers and quality measures from it. The product page lists an AI Assistant, real time Ambient CareCues for documentation and coding, and autonomous CPT and ICD-10 coding on the Ambient+ tier, and Commure presents the documentation output as the first step of its revenue cycle workflow.

Two service tiers add people on top of the model. Ambient Assist adds documentation specialists who review the AI draft, and Ambient Live adds real time human documentation support for higher acuity work. Around the ambient line Commure sells dictation, call center agents, revenue cycle management, the Engage patient engagement product, Athelas Home and the Strongline staff safety system, and the self serve Commure Scribe is sold separately to smaller practices.

Human involvement is built into the product tiers. The Augmedix suite was sold as Go, which is AI only, Assist, which adds specialist review of the AI draft, and Live, which provides synchronous human documentation. Commure now offers the same ladder as Ambient AI, Ambient Assist and Ambient Live, describing Assist as asynchronous specialist support and Live as real time support at the point of care. Its September 2026 regulatory announcement states that clinicians review and sign off on every note before it enters the record.

Coding runs with less stated oversight. The Ambient+ tier advertises autonomous CPT and ICD-10 coding that eliminates manual coding steps, built by specialty to reach 95%+ alignment with gold standard coders. The self serve Commure Scribe says users review and approve suggested codes before submission, and the Terms of Use make users responsible for verifying AI generated content before relying on it. For the enterprise coding engine, the point at which a coder or clinician sees a code before the claim goes out, and what the engine does when it is uncertain, are not described.

The ambient technology is described as language models that transcribe and code. Commure Scribe's pages say more: a proprietary large language model that evaluates the entire transcript in context, a transcription model Commure calls 99.4% accurate, and models that improve with each use. For health systems Commure claims 95%+ alignment with gold standard coders and high accuracy across more than 100 languages. None of those figures comes with a method or test set, and no model card, version history or update policy is published.

Product lineage complicates the picture. The ambient capability has reached customers as Commure Ambient AI, Commure Scribe and the Augmedix Go, Assist and Live tiers, across a group assembled through five acquisitions in three years. In June 2026 Commure said it could apply Anthropic's Mythos class models across its platform, without naming the products that use them. Which engine produces a given customer's note, and whether it is the engine the KLAS score and pilot results were earned on, is not stated.

Hosting is named and the model layer is not tied to a product. The trust center lists Amazon Web Services and Azure as infrastructure. In June 2026 Commure said it had done the security, compliance and architecture work to deploy Anthropic's Mythos class models within its own environment and could apply them across the platform, without saying which products use them. Commure Scribe's pages describe a proprietary large language model, and the Scribe FAQ says Commure never shares data with third parties and owns the entire data pipeline.

The first link in the chain is also open. The ambient capability has been sold as Commure Ambient AI, Commure Scribe and the Augmedix tiers, and nothing published says which engine produces the note a given customer receives. No subprocessor list is published, and no model version is tied to a product.

Customer perception surveys and two head to head pilots that Commure reports make up the published evidence. A 2025 KLAS First Look report scored Commure Ambient AI at 93.3, with every respondent saying they would buy it again, based on interviews with a selected sample of customers; a First Look measures what customers report rather than a controlled outcome. Vizient awarded Augmedix a contract for the suite in January 2025.

North East Medical Services ran a ten week pilot against another large Epic integrated scribe, announced in February 2025, and Commure reports 5.2 minutes saved per encounter against 3.6, note quality rated 4.5 out of 5 against 3.8, and a 30 percent improvement in documentation efficiency. At Willis Knighton Health, a pilot across eight specialties found more than 80 percent of participating clinicians preferred Commure to the competing vendor, 95 percent would recommend it and 88 percent reported less time in the chart. Neither publication gives the number of clinicians or encounters, or how the figures were collected.

The product page adds up to two hours of documentation time saved per day depending on specialty, a 10 percent increase in wRVUs per clinician and a 25 percent average reduction in denials, with no method or denominator. No peer reviewed study of the product is published. Commure's own pricing analysis notes that the only published randomized controlled trial of ambient scribing tools found modest effects that varied by tool.

Ownership and deidentification are set out in Commure's contracts. Under the General Terms of Agreement the customer owns its Customer Data, a term defined to exclude PHI, and Commure makes stored Customer Data available on written request after termination. The same terms let Commure create deidentified data, own it outright, use and disclose it for any purpose the law does not prohibit, and aggregate it with other customers' deidentified data to produce insights. PHI itself falls under the Business Associate Agreement, which permits deidentification only through a tokenization vendor and requires return or destruction at termination.

Commure Scribe adds product level statements: Commure never shares data with third parties, owns the entire data pipeline, and runs proprietary language models that improve with each use.

Whether PHI, or the deidentified data derived from it, trains those models is not stated, and the trust center's AI Training Data and Bias document is open only to approved reviewers. No retention period for audio or transcripts is published, and Commure publishes nothing on guardrails, hallucination mitigation or how a safety event is handled.

The standard Business Associate Agreement is published on commure.com, effective for all service agreements entered after June 24, 2025 that involve protected health information, and is incorporated into the underlying agreement. Commure reports a use or disclosure the agreement does not permit without unreasonable delay and no more than 30 days after discovery, signs a written agreement with any subcontractor that handles PHI on its behalf, and at termination returns or destroys the PHI at the covered entity's expense and keeps no copies.

The agreement also lets Commure use PHI for its own management and administration, provide data aggregation services for the customer's health care operations, and deidentify PHI under the HIPAA standard through a vendor that applies tokenization, with Commure barred from holding the tokens that could reidentify it.

On its trust center Commure says it designs its privacy and security practices to support HIPAA and aligns its program with the NIST Cybersecurity Framework and HITRUST, and it offers a HIPAA report to approved reviewers. No HITRUST certification is claimed.

Regular SOC 2 Type II examinations are part of Commure's security program, according to its trust center at trust.commure.com, and approved reviewers can request the SOC 2 report, a HIPAA report and a penetration test report there. The compliance list also names Cyber Essentials, ISO/IEC 27001, ISO/IEC 42001:2023, NIST CSF and TX-RAMP, with no certificate, scope or status shown on the public page.

Control areas are listed by title, among them access log management, endpoint detection and response, mobile device management, event and audit log management and application penetration testing, and Commure carries cyber insurance. The report period, the entities and products in scope, and whether the examination covers the ambient products are visible only to approved reviewers.

Class I medical device software status under EU MDR 2017/745, with a CE mark, and registration with the UK MHRA under the Medical Devices Regulations 2002 were announced for Commure Ambient AI on September 3, 2026, both self certified for UK and EU deployment. Commure classifies the product under MDR Rule 11 and says its technical file includes a clinical evaluation, hazard analysis under ISO 14971 and usability testing under IEC 62366-1. No FDA clearance is claimed for the US market.

The Terms of Use, effective November 18, 2025, state that the services do not substitute for professional medical judgment and are not designed or appropriate to address serious, emergent or life threatening conditions, and that AI features assist rather than replace professional judgment.

Coding sits closest to that line. The Ambient+ tier generates CPT and ICD-10 codes autonomously, while the same terms make users responsible for verifying AI generated content before relying on it, so the product page and the contract describe different levels of human involvement in the coding step.

Language performance is the one area where Commure has published comparative results. In the North East Medical Services pilot announced in February 2025, Commure reported what it calls documentation edit rates of 95 percent for Spanish and 93 percent for Chinese language encounters, against 82 and 78 percent for the competing product, without defining the measure or the number of encounters.

The rest of the governance material is listed by title. The trust center lists AI Governance and AI Training Data and Bias documents for approved reviewers, and ISO/IEC 42001:2023, the AI management system standard, appears in its compliance list with no certificate or status shown publicly. The Terms of Use state that AI outputs may be incomplete, inaccurate or biased.

Commure markets high accuracy across more than 100 languages for health systems and 60+ for Commure Scribe, and publishes results for the two languages above only. No fairness method, results by accent or patient group, or analysis of autonomous coding errors by payer or population is public.

Commure's Terms of Use, effective November 18, 2025, include a section on AI features: outputs may be incomplete, inaccurate or biased, the features assist rather than replace professional judgment, users must verify AI generated content before relying on it, and Commure disclaims liability for actions taken in reliance on those outputs. The services are provided as is. In states that do not allow the exclusion of incidental or consequential damages, liability is limited to the lesser of $5,000 or twelve months of fees. Users indemnify Commure, claims must be brought within one year, and disputes go to confidential binding arbitration in Santa Clara County under JAMS rules and Delaware law, with a class action waiver and a 30 day opt out at opt_out@commure.com.

The General Terms of Agreement that govern health system statements of work cap liability at twelve months of fees, disclaim any warranty of accuracy, and state that Commure does not promise results such as first pass rate, denial rate or collections. They also commit Commure to defend the customer against successful claims arising from Commure's negligence or willful misconduct and against intellectual property claims, subject to that cap. Neither document attaches a remedy to an incorrect note or code, and no route is described for a patient affected by one.

The published accuracy figures, 99.4% transcription accuracy for Commure Scribe and 95%+ alignment with gold standard coders, carry no method or denominator. When Commure announced Mythos class models in June 2026 it told customers they keep the same deployment, workflows and integrations; the terms say nothing about notice when the model behind a product changes.

Epic is Commure's most documented integration. Commure Ambient AI holds Epic Toolbox designation for Ambient Voice, announced April 30, 2025: notes captured in the Haiku mobile app flow into Hyperdrive for the clinician's final review and editing. North East Medical Services runs the product fully integrated with Epic, and the product page describes syncing patient data and documentation directly with the EHR.

Beyond Epic, Augmedix Go was documented across more than 50 EHRs including Oracle Health and MEDITECH, and Commure now describes its ambient and revenue cycle software as integrated with 60+ EHRs. The self serve Commure Scribe lists connectors for athenahealth, AdvancedMD, Cerbo, eClinicalWorks, Elation, Kipu, MEDITECH, Practice Fusion, SimplePractice, Tebra and WebPT, with direct EHR sync on the Enterprise plan.

Which elements reach each system as discrete data, such as codes, orders and charges, rather than as note text is not set out system by system.

Amazon Web Services and Azure appear under infrastructure on Commure's trust center, along with container orchestration, and Commure is listed as an AWS Partner. A region is committed only for the UK, where Commure Ambient AI is available with UK data residency, aligned with UK GDPR and designed for NHS procurement.

For US customers no country or region is named, and no dedicated tenancy, private network or on premises option is published. The product includes an offline mode so clinicians can document without a connection.

Commure sells the ambient line two ways, and only the self serve one carries a price. Commure Scribe's pricing page offers ScribeCore free for seven days with no card required, ScribePro at $708 a year billed annually, shown against a list price of $1,068, and ScribeEnterprise on a custom quote with templates built for the practice and notes synced to the EHR; the page description gives plans from $59 a month. Automated ICD-10 and CPT coding comes with every plan, and cancellations, including annual subscriptions, are not refunded.

The health system offer has no published rate. Commure Ambient AI, the Assist and Live service tiers and the revenue cycle services sold beside them are quoted, and Vizient member health systems reach them through a negotiated contract. Commure also publishes a pricing analysis of ambient scribe products that names competitors' per user rates.

Inpatient, ambulatory, procedural and high acuity workflows all fall within Commure Ambient AI's stated range, and the product page names 25 specialties, among them cardiology, emergency medicine, oncology, hospitalist care, critical care, wound care, nephrology and electrophysiology. Commure says its models, prompts and formats adapt to each specialty. The AI only tier is aimed at ambulatory and lower acuity settings, with the staffed tiers covering more complex work, and Augmedix markets a dedicated emergency medicine app and AI tuned for oncology.

Named deployments back part of that range: North East Medical Services, where the pilot measured Spanish and Chinese language encounters, an eight specialty pilot at Willis Knighton Health, and a co development partnership with HCA Healthcare covering emergency departments and hospitalist operations. Commure lists more than 130 health systems and 3,000 sites of care.

The enterprise product claims more than 100 languages and the self serve Commure Scribe 60+, with Scribe also covering behavioral health, psychiatry and dentistry. In September 2026 Commure Ambient AI gained a CE mark and UK registration, and Commure describes it as used in more than 50 countries. Accuracy by specialty is not published.